Usage of infliximab biosimilars in select countries 2018

Uptake of infliximab biosimilars in select countries as of 2018, by share of units

CharacteristicShare of units
Norway 98%
Poland 96%
United Kingdom 92%
Austria 89%
Italy 79%
Sweden 78%
Slovenia 64%
Portugal 63%
France 60%
Czechia 59%
Spain 56%
Germany 53%
Ireland 40%
Created with Highcharts 7.2.2Share of units98%98%96%96%92%92%89%89%79%79%78%78%64%64%63%63%60%60%59%59%56%56%53%53%40%40%37%37%36%36%30%30%23%23%22%22%17%17%17%17%16%16%9%9%8%8%7%7%NorwayPolandUnited KingdomAustriaItalySwedenSloveniaPortugalFranceCzechiaSpainGermanyIrelandSouth KoreaSlovakiaBelgiumTurkeySwitzerlandMexicoFinlandAustraliaJapanCanadaUnited States
0%5%10%15%20%25%30%35%40%45%50%55%60%65%70%75%80%85%90%95%100%105%110%
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2020

Region

OECD

Survey time period

as of Q4 2018

Supplementary notes

Countries with limited data were excluded from the analysis.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Leading companies trust Statista:
paypal google adobe pg samsung telekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on " Medical biotech industry "

Other statistics that may interest you Medical biotech industry

Global overview

7

Research & development

6

R&D country comparison

3

Products

4

Funding/M&A/IPOs

5

Focus: U.S. companies

6

Focus: RNA/mRNA

3

Discover Statista

Need help with using Statista for your research? Tutorials and first steps
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.